Wistar Receives $4.7 Million from Wellcome Trust to Develop Drug Against Cancers Caused by Epstein-Barr Virus
Thursday, December 15, 2011 - 17:00
in Health & Medicine
The Wistar Institute today announced that it has signed a funding agreement with the Wellcome Trust, a United Kingdom-based charity, to support the development of a new drug to treat cancers associated with Epstein-Barr virus (EBV).